Recent progress in advanced cardiac life support

Air Medical Journal

Volumn 19, Issue 2, 2000, Pages 38-46

  Dries, David J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ADULT; CARDIOVERSION; DRUG DELIVERY SYSTEM; ENDOTRACHEAL INTUBATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; LONG TERM CARE; METHODOLOGY; RESUSCITATION; REVIEW;

ADULT; ANTI-ARRHYTHMIA AGENTS; CARDIOPULMONARY RESUSCITATION; DRUG DELIVERY SYSTEMS; ELECTRIC COUNTERSHOCK; HUMANS; INTUBATION, INTRATRACHEAL; LIFE SUPPORT CARE; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0034170827     PISSN: 1067991X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1067-991X(00)90070-1     Document Type: Review

References (66)

1. Ryan TJ, Andersen JL, Antman EM, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: executive summary. Circulation 1996;94:2341-50.
2. Montgomery WH, Brown DD, Clawsen J, et al. Citizen response to cardiopulmonary emergencies. Ann Intern Med 1993;22:162-8.
3. Gonzalez ER. Pharmacologic controversies in CPR Ann Emerg Med 1993;22(part 2):317-23.
4. Surawicz B. Ventricular fibrillation. J Am Coll Cardiol 1985;5:438-48.
5. Roth R, Stewart RD, Rogers K, Cannon GM. Out-of-hospital cardiac arrest: factors associated with survival. Ann Emerg Med 1984;13:237-43.
6. Ekstrom L, Herlitz J, Wennerblom B, Axelsson A, Bang A, Holmberg S. Survival after cardiac arrest outside hospital over a 12-year period in Gothenburg. Resuscitation 1994;27:181-8.
7. Robertson C, Steen P, Adgey J, et al. The 1998 European Resuscitation Council guidelines for adult advanced life support. Resuscitation 1998;37:81-90.
8. Larsen MP, Eisenberg MS, Cummins RO, Hallstrom AP. Predicting survival from out-of-hospital cardiac arrest: a graphic model. Ann Emerg Med 1993;22:1652-8.
9. Greene HL, Dimarco JP, Kudenchuk PJ, et al. Comparison of monophasic and biphasic defibrillating pulse waveforms for transthoracic cardioversion. Am J Cardiol 1995;75:1135-9.
10. Bardy GH, Gliner BE, Kudenchuk PJ, et al. Truncated biphasic pulses for transthoracic defibrillation. Circulation 1995;91:1768-74.
11. Kerber RE, Martins JB, Kienzle MG, et al. Energy, current and success in defibrillation and cardioversion: clinical studies using an automated, impedance-based energy adjustment method. Circulation 1988;77:1038-46.
12. Brimacombe JR, Berry A The incidence of aspiration associated with the laryngeal mask airway: a meta-analysis of published literature. J Clin Anaesth 1995;7:297-305.
13. Owens TM, Robertson P, Twomey C, et al. The incidence of gastroesophageal reflux with the laryngeal mask. Anesth Analg 1995;80:980-4.
14. Baskett PJF, Bossaert L, Carli P, et al. Guidelines for the advanced management of the airway and ventilation during resuscitation. A statement by the Airway and Ventilation Management Group of the ERC. Resuscitation 1996;31:201-30.
15. Davis K, Johannigman JA, Johnson RC, Branson RD. Lung compliance following cardiac arrest. Acad Emerg Med 1995;2:874-8.
16. Barsan WG, Levy RC, Weir H. Lidocaine levels during CPR Ann Emerg Med 1981;10:73-8.
17. Keats S, Jackson RE, Kosnik JW, et al. Effect of peripheral versus central injection of epinephrine on changes in aortic diastolic blood pressure during closed-chest massage in dogs [abstract]. Ann Emerg Med 1985;14:495.
18. Redding JS, Pearson JW. Effective routes of drug administration during cardiac arrest. Anesth Analg 1967;46:253-8.
19. Pentel P, Benowitz N. Pharmacokinetic and pharmacodynamic considerations in drug therapy of cardiac emergencies. Drugs 1984;9:273-308.
20. Talit U, Braun S, Halkin H, et al. Pharmacokinetic differences between peripheral and central drug administration during cardiopulmonary resuscitation. J Am Coll Cardiol 1985;6:1073-7.
21. Raehl CL. Endotracheal drug therapy in cardiopulmonary resuscitation. Clin Pharm 1986;5:572-9.
22. Hasegawa EA The endotracheal administration of drugs. Heart Lung 1986;15:60-3.
23. Roberts JR, Greenberg MI, Knauh M, et al. Comparison of the pharmacological effects of epinephrine administered by intravenous and endotracheal routes. JACEP 1978;7:260-4.
24. Greenberg MI, Baskin SI, Kaplan AM, et al. Effects of endotracheally administered distilled water and normal saline on the arterial blood gases of dogs. Ann Emerg Med 1982;11:6004.
25. 2 with endobronchial administration: dilution with normal saline or distilled water. Ann Emerg Med 1990;19:1314-7.
26. Ralston SH, Tacker WA, Showen L, et al. Endotracheal versus intravenous epinephrine during electromechanical dissociation with CPR in dogs. Ann Emerg Med 1985;14:1044-8.
27. Aitkenhead AR. Drug administration during CPR what route? Resuscitation 1991;22:191-5.
28. Kuhn GJ, White BC, Swetman RE, et al. Peripheral versus central circulation time during CPR: a pilot study. Ann Emerg Med 1981;10:417-9.
29. Quintan DN, O'Byrne G, Aitkenhead AR. Comparison of endotracheal and peripheral intravenous adrenaline in cardiac arrest. Is the endotracheal route reliable? Lancet 1987;1:828-9.
30. Redding JS, Pearson JW. Adrenaline in cardiac resuscitation. Am Heart J 1963;66:210-4.
31. Steill IG, Hebert PC, Weitzman BW, et al. High dose epinephrine in adult cardiac arrest. N Engl J Med 1992;327:1045-50.
32. Brown CG, Martin DR, Pepe PE, et al. A comparison of standard-dose and high-dose epinephrine in cardiac arrest outside the hospital: the Multicenter High-dose Epinephrine Study Group. N Engl J Med 1992;327:1051-5.
33. Herbert PC, Steill IG, Wells GA, et al. Do advanced cardiac life support drugs increase resuscitation rates from in-hospital cardiac arrest? Ann Emerg Med 1998;32:544-53.
34. Steill IG, Herbert PC, Wells GA, et al. The Ontario trial of active compression-decompression cardiopulmonary resuscitation for in-hospital and pre-hospital cardiac arrest. JAMA 1996;275:1417-23.
35. Harrison EE. Lidocaine in prehospital countershock refractory ventricular fibrillation. Ann Emerg Med 1981;10:420-3.
36. Davis J, Classman R, Witt AL. Method for evaluating the effect of antiarrhythmic drugs on ventricular tachycardias in the infarcted canine heart. Am J Cardiol 1982;49:1176-84.
37. Josephson ME, Horowitz LN, Forshidi A, Kastor JA Recurrent sustained ventricular tachycardia. I Mechanism. Circulation 1978;57:431-41.
38. Gorgels APM, van den Dool A, Hofs A, et al. Comparison of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Am J Cardiol 1996;78:43-6.
39. Mark LC, Kayden HJ, Steele JM, et al. The physiological disposition and cardiac effects of procainamide. J Pharmacol Exp Ther 1951;102:5-15.
40. Giardina EV, Heissenbuttel RH, Bigger JT. Intermittent intravenous procainamide to treat ventricular arrhythmias. Ann Int Med 1973;78:183-93.
41. Kock-Weser J, Klein SW. Procainamide dose schedules, plasma concentrations, and clinical effects. JAMA 1971;215:1454-60.
42. Greene H, Roden D, Katz R, Woosley R, Salerno D, Henthorn R. The Cardiac Arrhythmia Suppression Trial: first CAST I then CAST II. J Am Coll Cardiol 1992;19:894-8.
43. Naccarelli GV, Jala S. Intravenous amiodarone. Another option in the acute management of sustained ventricular tachyarrhythmias. Circulation 1995;92:3154-5.
44. Mason JW. Amiodarone. N Engl J Med 1987;316:455-66.
45. Amiodarone Trials Meta-Analysis Investigators. Effect of prophylactic amiodarone on mortality after acute myocardial infarction in congestive heart failure. Lancet 1997:15:1417-24.
46. Kudenchuk P, Cobb LA, Copass MK, et al. Amiodarone for resuscitation after out-of-hospital cardiac arrest due to ventricular fibrillation. N Engl J Med 1999;341:871-8.
47. Vaughan-Williams EM. A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984;24:12947.
48. Cobbe S. Clinical usefulness of the Vaughan-Williams classification system. Eur Heart J 1987;8(Suppl A):65-9.
49. Fain ES, Lee SJ, Winkle RA. Effects of intravenous and chronic oral amiodarone on defibrillation energy requirements. Am Heart J 1987;114:8-17.
50. Gonzalez ER, Kannewurf BS, Ornato JP. Intravenous amiodarone for ventricular arrhythmias: overview and clinical use. Resuscitation 1998;39:33-42.
51. Remme WJ, Kruyssen ACM, Look PM. Hemodynamic effects and tolerability of intravenous amiodarone in patients with impaired left ventricular function. Am Heart J 1991;122:96-103.
52. Podrid P. Amiodarone: reevaluation of an old rug. Ann Intern Med 1995;122:689-700.
53. Holt AW. Hemodynamic responses to amiodarone in critically ill patients receiving catecholamine infusions. Crit Care Med 1989; 17:1270-6.
54. Veltri EP, Reid PR. Sinus arrest with intravenous amiodarone. Am J Cardiol 1986;58:1110-1.
55. Kosinski EJ, Albin JB, Young E. Hemodynamic effects of intravenous amiodarone. J Am Coll Cardiol 1984;4:565-70.
56. Myers RE, Yamaguchi M. Nervous systems effects of cardiac arrest in monkeys. Arch Neurol 1977;34:65-74.
57. D'Alecy LG, Lundy EF, Barton KJ, et al. Dextrose-containing intravenous fluid impairs out-come and increases death after eight minutes of cardiac arrest and resuscitation in dogs. Surgery 1986;100:505-11.
58. Longstreth WT, Inui TS. High blood glucose level on hospital admission and poor neurological recovery after cardiac arrest. Ann Neurol 1984;15:59-63.
59. Longstreth WI, Diehr P, Cobb LA, et al. Neurologic outcome and blood glucose levels during out-of-hospital cardiopulmonary resuscitation. Neurology 1986;36:1186-91.
60. Martin GB, O'Brien JF, Best R, et al. Insulin and glucose levels during CPR in the canine model. Ann Emerg Med 1985;14:293-7.
61. Lindner KH, Strohmenger HU, Ensinger H, Hetzel WD, Ahnefeld FW, Georgieff M. Stress hormone response during and after cardiopulmonary resuscitation. Anesthesiology 1992;77:662-8.
62. Lindner KH, Haak T, Keller A, Bothner U, Lurie KG. Release of endogenous vasopressors during and after cardiopulraonary resuscitation. Br Heart J 1993;75:145-50.
63. Lindner KH, Brinkmann A, Pfenninger EG, Lurie KG, Goertz A, Lindner IM. Effect of vaso pressin on hemodynamic variables, organ blood flow, and acid-base status in a pig model of cardiopulmonary resuscitation. Anesth Analg 1993;77:427-35.
64. Lindner KH, Prengel AW, Pfenninger EG, et al. Vasopressin improves vital organ blood flow during closedchest cardiopulmonary resuscita-tion in pigs. Circulation 1995;91:215-21.
65. Lindner KH, Prengel AW, Brinkmann A, Strohmenger HU, Lindner IM, Lurie KG. Vasopressin administration in refractory cardiac arrest. Ann Intern Med 1996;124:10614.
66. Lindner KH, Dirks B, Strohmenger HU, Prengel AW, Lindner IM, Lurie KG. Randomized comparison of epinephrine and vasopressin in patients with out-of-hospital ventricular fibrillation. Lancet 1997;349:535-7.